Exploring Antacids world in 2024
Introduction
Antacids play a crucial role in managing acid-related disorders, providing relief from discomfort caused by excess stomach acid. In this blog, we’ll look at the various aspects of antacids, from their type and pharma global market size to the manufacturers and the latest trends, in this comprehensive blog.
Types of Antacids
Antacids may be in a variety of forms, such as tablets and liquids. These preparations neutralize stomach acid, which alleviates symptoms such as heartburn, indigestion and acidity. Some common antacid ingredients include:
- Calcium Carbonate: Works by providing quick relief by neutralizing acid.
- Magnesium Hydroxide: Used as both antacid and laxative in products like Milk of Magnesia.
- Aluminum Hydroxide: It is frequently combined with other ingredients to provide lasting relief.
Global Market Size
- The world pharma market size for antacid amounted to USD 6,810.11 million during the year 2023.
- It is expected to grow at a compound annual growth rate of 3.7% to reach USD 8,194.33 million by 2028. (Courtesy: Mordor Intelligence)
- From 2023 to 2030, it is expected to grow at a compound annual growth rate (CAGR) of 3.7%. (Courtesy: Grand View Research)
- The main growth drivers are changing dietary habits and an increase in the occurrence of acidic disorders.
Indian market
- Due to lifestyle changes, stress, and irregular eating patterns, antacids are commonly used in India. Increased awareness and availability of OTC antacids are driving steady growth in the market.
- The incidence of GERD in the outpatient has reached 20% or more.
- The demand for antacids to treat GERD will increase as the elderly population is expected to increase to 94.7 million by 2060. (Courtesy: Mordor Intelligence)
- Top Indian Antacid brands available includes- BRORAB-LS, OMITOK-D, Celocid, DIgene, Biocil MPS, etc.
Top players in antacid market
Glaxosmithkline plc, Bayer AG, Pfizer Inc., AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd and others are major players in the antacid market.
Global Scenario
Globally, 783.95 million people were diagnosed with gastroesophageal reflux disease (GERD) in 2019. (Courtesy: Grand View Research)
Antacid Manufacturers
The antacids are manufactured by some of the world’s leading pharmaceuticals companies, ensuring their quality and efficacy. These producers are involved in the OTC and prescription markets.
The manufacture of antacids that help to remove excess gastric acid associated with gastritis or peptic ulcers plays a crucial role. Alardius Healthcare, Innovexia Life Sciences Private Limited, Biozenta Lifescience PVT Ltd., Uniroyal Biotech and Ayucare Pharmaceuticals are some of the best active pharmaceutical ingredient manufacturers in India for antacids.
Self-medication with antacid is possible over-the-counter, but caution should be exercised and consultations with a healthcare professional are advised in case of persisting signs.
Latest Updates
- E-commerce: Demand for antacids is driven by online retail channels, offering convenience to consumers.
- Geriatric Population: Older people are more susceptible to stomach problems and this increases the use of antacids.
- Combination Therapies: Antacids are part of treatment regimens for acid complications like Barrett’s esophagus and esophageal cancer.
Chemxpert Database
Chemxpert database, a pharma database service provider company is a complete source of information on antacid . It contains essential information, such as active substances, technical details and commercial terms. Data on market size, suppliers and buyers’ information, regulatory data, patent status or timely updates shall be made available to researchers and manufacturers. All valuable information on antacids is contained in the Chemxpert database, which covers a large number of molecules. Simethicone, calcium carbonate, calcium carbonate, magnesium carbonate, and more are among the few antacid chemicals included in the database.
Conclusion
Antacids are still essential to the management of acid associated discomfort. Continuous improvements in antacid therapy will be driven by collaboration between manufacturers, healthcare providers and chemical databases as the global market expands.
